Captrust Financial Advisors Alkermes Plc. Transaction History

Captrust Financial Advisors

  • $33 Billion
  • Q3 2024

A detailed history of Captrust Financial Advisors transactions in Alkermes Plc. stock. As of the latest transaction made, Captrust Financial Advisors holds 16,743 shares of ALKS stock, worth $496,429. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,743
Previous 17,384 3.69%
Holding current value
$496,429
Previous $418,000 11.96%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$23.01 - $28.55 $14,749 - $18,300
-641 Reduced 3.69%
16,743 $468,000
Q2 2024

Aug 14, 2024
BUY
$23.21 - $27.24 $45,816 - $53,771
1,974 Added 12.81%
17,384 $418,000
Q1 2024

May 15, 2024
SELL
$26.4 - $32.56 $335,649 - $413,967
-12,714 Reduced 45.21%
15,410 $417,000
Q4 2023

Feb 14, 2024
BUY
$23.37 - $28.68 $99,182 - $121,717
4,244 Added 17.77%
28,124 $780,000
Q3 2023

Nov 14, 2023
BUY
$27.17 - $31.97 $225,945 - $265,862
8,316 Added 53.43%
23,880 $668,000
Q2 2023

Aug 14, 2023
BUY
$28.34 - $33.63 $30,862 - $36,623
1,089 Added 7.52%
15,564 $487,000
Q1 2023

May 15, 2023
BUY
$25.31 - $29.02 $27,157 - $31,138
1,073 Added 8.01%
14,475 $408,000
Q4 2022

Feb 15, 2023
BUY
$21.94 - $26.24 $12,176 - $14,563
555 Added 4.32%
13,402 $350,000
Q3 2022

Nov 16, 2022
BUY
$22.0 - $31.87 $265,650 - $384,830
12,075 Added 1564.12%
12,847 $287,000
Q2 2022

Aug 23, 2022
SELL
$26.4 - $30.54 $171,758 - $198,693
-6,506 Reduced 89.39%
772 $23,000
Q2 2022

Aug 16, 2022
BUY
$26.4 - $30.54 $8,553 - $9,894
324 Added 4.66%
7,278 $217,000
Q1 2022

May 16, 2022
BUY
$23.07 - $27.99 $148,640 - $180,339
6,443 Added 1260.86%
6,954 $183,000
Q4 2021

Feb 14, 2022
BUY
$21.47 - $32.08 $4,981 - $7,442
232 Added 83.15%
511 $12,000
Q3 2021

Nov 16, 2021
BUY
$23.37 - $32.13 $70 - $96
3 Added 1.09%
279 $9,000
Q1 2021

May 17, 2021
SELL
$18.21 - $23.2 $13,821 - $17,608
-759 Reduced 73.33%
276 $5,000
Q4 2020

Feb 16, 2021
SELL
$15.39 - $22.1 $22,777 - $32,708
-1,480 Reduced 58.85%
1,035 $21,000
Q3 2020

Nov 17, 2020
SELL
$16.16 - $20.66 $60,196 - $76,958
-3,725 Reduced 59.7%
2,515 $41,000
Q2 2020

Aug 14, 2020
BUY
$13.31 - $19.41 $83,054 - $121,118
6,240 New
6,240 $123,000
Q4 2019

Feb 14, 2020
SELL
$17.29 - $21.74 $107,889 - $135,657
-6,240 Closed
0 $0
Q3 2018

Nov 15, 2018
BUY
$38.6 - $46.12 $240,864 - $287,788
6,240 New
6,240 $265,000

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.87B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email